Added benefit of the fixed combination of dapagliflozin and metformin is not proven

(Institute for Quality and Efficiency in Health Care) As was the case in dapagliflozin monotherapy, the drug manufacturer also presented no suitable data for the therapeutic indication in its dossier on the fixed combination with metformin.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news